Neochem Bio IPO Financials
The Neochem Bio IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 30 Sep 2025, Neochem Bio Solutions Limited reported assets of ₹96.49 crore, revenue of ₹47.18 crore, and a profit after tax (PAT) of ₹5.48 crore. The company had a net worth of ₹32.24 crore and reserves & surplus of ₹19.7 crore, and total borrowings are 38.54 crore.
Revenue increased by 82.60% in 31 Mar 2025 and decreased by 28.02% in 31 Mar 2024 and decreased by 21.32% in 31 Mar 2023, while Profit After Tax (PAT) grew by 41.42% in 31 Mar 2025 and declined by 76.77% in 31 Mar 2024 and declined by 40.56% in 31 Mar 2023, respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Neochem Bio Solutions Limited Financials (₹ in Crores)
| Particular | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 96.49 | 78.89 | 64.06 | 50.6 |
| Revenue | 47.18 | 86.15 | 62.01 | 48.79 |
| Profit After Tax | 5.48 | 7.75 | 1.8 | 1.07 |
| Net Worth | 32.24 | 19.75 | 12 | 8.05 |
| Reserve & Surplus | 19.7 | 13.08 | 5.33 | 2.63 |
| Total Borrowings | 38.54 | 35.62 | 33.32 | 26.24 |
EPS Pre
6.18%
EPS Post
6.41%
P/E Pre
15.85
P/E (Post Issue)
15.30x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Neochem Bio Solutions Limited?
Neochem Bio Solutions Limited reported revenue of ₹47.18 crore as of 30 Sep 2025 . Revenue figures from the Neochem Bio IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Neochem Bio Solutions Limited?
Neochem Bio Solutions Limited reported a Profit After Tax (PAT) of ₹5.48 crore as of 30 Sep 2025 . PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Neochem Bio Solutions Limited?
Neochem Bio Solutions Limited has a Price-to-Earnings (P/E) ratio of 15.85x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.